Axiron Approval History
FDA Approved: Yes (Discontinued) (First approved November 23, 2010)
Brand name: Axiron
Generic name: testosterone
Dosage form: Topical Solution
Company: Eli Lilly and Company
Treatment for: Hypogonadism, Male
Marketing Status: Discontinued
Axiron (testosterone) is an androgen indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.
The FDA posted a notice regarding the discontinuation of manufacture of Axiron in September 2017. The product was not discontinued or withdrawn for safety or efficacy reasons.
Development History and FDA Approval Process for Axiron
|Nov 24, 2010||Lilly and Acrux Receive FDA Approval for Axiron (Testosterone) Topical Solution CIII|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.